The Effect of and Agonist on the Proliferation and Differentiation of Osteoblast |
Heo, Jeong-Mi
(Department of Periodontology, College of Dentistry, Seoul National University)
Kim, Kyoung-Wha (Department of Periodontology, College of Dentistry, Seoul National University) Chung, Kyoung-Wook (Department of Periodontology, College of Dentistry, Seoul National University) Lee, Hye-Joon (Department of Periodontology, College of Dentistry, Seoul National University) Rhyu, In-Chul (Department of Periodontology, College of Dentistry, Seoul National University) Ku, Young (Department of Periodontology, College of Dentistry, Seoul National University, Intellectual Biointerface Engineering Center, KOSEF) Chung, Chong-Pyoung (Department of Periodontology, College of Dentistry, Seoul National University, Intellectual Biointerface Engineering Center, KOSEF) |
1 | Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Nad Acad Sci (USA) 1992;89:7384-7388 DOI ScienceOn |
2 | jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 1993;268:9049-9054 |
3 | Gardner CR, Blanque R, Cottereaux C. Mechanism involved in prostaglandin-induced increase in bone resorption in neonatal mouse calvaria. Prostaglandins Leukot Essent Fatty Acids 2001;64:117-125 DOI ScienceOn |
4 | Bezerra MM, de Lima V, Alencar VBM, Vieira IB, Brito GA, Ribeiro RA, Rocha FA. Selective cyclooxygenase-2 inhibiton prevents alveolar bone loss in experimental periodontitis in rats, J Periodontol 2000;71:1009-1014 DOI ScienceOn |
5 | Yalcin F, Basegmez C, Isik G, Berber L, Eskinazi E, Soydinc M, Issever H, Onan U. The effects of periodontal therapy on intracrevicular prostaglandin E2 concentrations and clinical parametners in pregnancy. J Periodontol 2002;73(2):173-177 DOI ScienceOn |
6 | Tasaki Y, Takamori R, Koshihara Y. Prostaglandin D2 metabolite stimulates collagen synthesis by human osteoblasts during calcification. Prostaglandins 1991;41(4):303-313 DOI ScienceOn |
7 | Yang RS, Liu TK, Linshiau SY. Increased bone growth by local prostaglandin E2 in rats. Calcif Tissue Int 1993;52:57-61 DOI ScienceOn |
8 | Takagi T, Yamamoto T, Asano S, Tamaki H. Effect of prostaglandin D2 on the femoral bone mineral density in ovariectomized rats. Calcif Tissue Int 1993;52(6):442-446. DOI ScienceOn |
9 | Thieringer R, Melody JF, Grand CB, Shelton BA, Detmers PA, Somers EP, Carbin L, Moller DE, Wright SD, Berger J. Activation of peroxisome proliferator-activated receptor does not inhibit IL-6 of TNF- responses of macrophages to lipopolysaccharide in vitro or in vivo. J Immunology 2000;164:1046-1054 |
10 | Jozkowicz A,Dulak J, Prager M, Nanobashvili J, Nigish A, Winter B, Weigel B, Huk I. Prostaglandin-J2 induces synthesis of interleukin8 by endothelial cells in a PPAR -independent manner. Prostaglandins & other Lipid Mediators 2001;66:165-177 DOI PUBMED ScienceOn |
11 | Hijiya N, Setoguchi M, Matsura K, Higuchi Y, Akizuki S, Yamamoto S. Cloning and characterization of the human osteopontin gene and its promoter. Biochern J, 1994;303:255-262 |
12 | Hughes-Fulford M, Fukushima M. Control of cell cycle by metabolites of prostaglandin D2 through a non-cAMP mediated mechanism. Life Sci Adv Exp Clin Endocrinol 1993;12:57-64 PUBMED |
13 | Ricote M, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998;391:79-82 DOI PUBMED ScienceOn |
14 | Altiok S, Xu M, Spiegelman BM. PPAR induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes & Development 1997;11:1987-1998 DOI ScienceOn |
15 | Quraishi O, Mancini JA, Riendeau D. Inhibition of inducible prostaglandin E2 synthase by 15-deoxy-12,14-prostaglandin]s and polyunsaturated fatty acids. Biochemical Pharmacology 2002;63:1183-1189 DOI PUBMED ScienceOn |
16 | Fahmi H, Battista JA, Pelletier JP, Mineau F, Ranger P, Pelletier JM. Peroxisome proliferatoractivated receptor yactivators inhibit interleukin-1 1induced nitric oxide and matrix metalloproteinase 13 production in human chondroeytes. Arthritis & Rheumatism 2001;44(3):595-607 DOI ScienceOn |
17 | Gelman L, Fruchart JC, Auwerx J. Review: An update on the mechanisms of action of the peroxisome proliferator -activated receptors (PP ARs) and their roles in inflammation and cancer CMLS, Cell Mol Life Sci 1999;55:932-943 DOI ScienceOn |
18 | Lehmann JM, Moore LB, Smith-Oliver TA, Wilkinson WO, Willson TM, Kliwer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator- activated receptor (PPAR) J Biol Chem 1995;270(22):12953-12956 DOI ScienceOn |
19 | Jackson SM, Derner LL. Peroxisome proliferatoractivated receptor activators modulate the osteblastic maturation of MC3T3-E1 preosteoblasts. FEBS 2000;471 :119-124 DOI ScienceOn |
20 | Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J 1989;259:315-324. PUBMED |
21 | Lee SH, Soyoola E, Chanmugam P, etal. selective expression of mitogen -inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 1992; 267:25934-25938 PUBMED |
22 | Koshihara Y and Kawamura M. Prostaglandin D2 stimulates calcification of human osteoblastic cells. Biochemical and Biophysical Research Communications 1989;159(3): 1206-1212 DOI ScienceOn |
23 | Azuma Y, Shinohara M, Wang PL, Ohura K. 15Deoxy- 12,14-prostaglandin J2 inhibits IL-10 and IL-12 production by macrophages. Biochemical and Biophysical Research Communications 2001;283:344-346 DOI PUBMED ScienceOn |
24 | Spiegelman BM. Perspectives in diabetes : PP AR- : adipogenic regulator and thiazolidine-dione receptor. Diabetes 1998;47:507-514 DOI PUBMED ScienceOn |
25 | Coleman RA, smith WL, Narumiya S. Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994;46:205-229 PUBMED |
26 | Qu Q, Perala-Hepeape M, Kapanen A, Dahllund J, Salo J, Vaananen HK, Harkonen P. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone 1998;22:201-209 DOI ScienceOn |
27 | Pagels WR, Sachs RT. Marnett LJ, Dewitt DL, Day JS, Smith WL. Immunochemical evidence for the involvement of prostaglandin H synthase in hydroperoxide-dependent oxidations by ram seminal vesicle microsomes. J Biol Chem 1983;258:6517-6523 PUBMED |
28 | Kraemer SA, Maeda EA, DeWitt DL. Prostaglandin endoperoxide synthase gene structure : identification of the transcriptional start site and 51-flanking regulatory sequences. Arch Biochem Biophy 1992;293:391-400 DOI ScienceOn |
29 | Petrova TV, Akama KT, Eldik LJ. Cyclopentenone prostaglandins suppress activation of microglia : down-regulation of inducible nitric-oxide synthase by 15-deoxy- 12 ,14-prostaglandin J2. Proc Natl Acad Sci USA 1999;96:4668-4673 DOI |
30 | Yu K, Bayona W, Kallen CB, Harding HP, Ravera CP, McMahon G, Brown M, Lazar MA. Differential activation of peroxisome proliferator-activated receptors by eicosanoeds. J Biol Chem 1995;270(41):23975-23983 DOI ScienceOn |
31 | Czemik BL, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL. Divergent effects of selective peroxisome proliferator-activated receptor- 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 2002;143(6):2376-2384 DOI PUBMED ScienceOn |
32 | Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator- activated receptor is a negative regulator of macrophage activation. Nature 1998;391(1):79-82 DOI PUBMED ScienceOn |
33 | Kikawa Y, Narumiya S, Fukushima M, Wakatsuka H, Hayaishi O. 9-Deoxy-9, 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma. Proc Natl Acad Sci USA 1984;81:1317-1321 DOI ScienceOn |
34 | Miyamoto T, Ogino N, Yamamoto S, Hayaishi O. Purification of prostaglandin endoperoxide synthetase form bovine vesicular gland microsomes. J Biol Chem 1976;251:2629-2636 PUBMED |
35 | Jee WSS, De no K, Deng YP, Woodbury DM. The effects of prostaglandin E2 in growing rats : increased metaphyseal hard tissue and corticoendosteal bone formation. Calcif Tissue Int 1985;37:148-157 DOI ScienceOn |
36 | Boyault S, Simonin MA, Bianchi A, Compe E, Liagre B, Mainard D, Becuwe P, Dauca M, Netter P, Terlain B, Borkji K. 15-deoxy-12,14-prostaglandin J2 but not troglitazone, modulates IL-1 effects in human chondrocytes by inhibiting NF- B and AP-1 activation pathways. FEBS Lett 2001;501(1):24-30 DOI PUBMED ScienceOn |
37 | Li L, Tao J, Davaille J, Fdral C, Mallat A, Rieusset J, Vidal H, Lotersztajn S. 15-deoxy-12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. J Biol Chem 2001 ;276(41):38152-38158 PUBMED |
38 | Lehmann JM, Lenhard JM, Oliver BB, Ringold Gm, Kliewer SA. Peroxisome proliferator-activated receptors and are activated by indomethacin and other non-steroidal antiinflammatory drugs. J Biol Chem 1997;272(6):3406-3410 DOI ScienceOn |
39 | Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL. Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res 1996;11:312-324 PUBMED |
40 | Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993;28:500-510 DOI PUBMED ScienceOn |
41 | Fukushima M. Prostaglandin J2-anti-tumour and anti-viral activities and mechanisms involved. Eicosanoids 1990;3:189-199 PUBMED |
42 | Guyton K, Bond R, Reilly C, Gilkeson G, Halushka P, Cook J. Differential effects of 15-deoxy-12,14-prostaglandin J2 and a peroxisome proliferator-activated receptor agonist on macrophage activation. J Leukoc Biol 2001;69(4):631-638 PUBMED |
43 | Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor and promotes adipocyte differentiation Cell 1995;83:813-819 DOI PUBMED ScienceOn |
44 | Mori S, Jee WSS, Li XJ, Chan S, Kimmel DB. Effects of prostaglandin E2 on production of new cancellous bone in the axial skeleton of ovariectomized rats, Bone 1990;11:103-113 DOI ScienceOn |
45 | Jee WSS, Mori S, Li XJ, Chan S. Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats, Bone 1990;11:253-266 DOI ScienceOn |
46 | Yuchang F, Nanlan LK, Maria F. Lopes V. Upregulation of interleukin-8 expression by prostaglandin D2 metabolite 15-deoxy-delta 12, 14 prostaglandin J2 (15d-PGJ2) in human TI-IP-1 macrophages. Atherosclerosis 2002;160:11-20 DOI ScienceOn |
47 | Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998;391:82-86 DOI PUBMED ScienceOn |
48 | Akatsu T, Takahachi N, Udagawa N, Imamura K, Yamaguchi A, Sato K, Nagata N, Suda T. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J Bone Miner Res 1991;6:183-190 PUBMED |
49 | Yoshiyuki H, Yoshinori N, Masahiki H, Eiko I, Masayoshi K. Inductive effects of prostaglandins on alkaline phosphatase in osteoblastic cells, clone MC3T3-E1. J Biochem 1085;97;97-104 |
50 | Nagata T, Kaho K, Nishikawa S, Shinihara H, Wakano Y, Ishida H. Effect of prostaglandin E2 on mineralization of bone nodules formed by fetal rat calvarial cells. Calcif Tissue Int 1994;55:451-457 DOI ScienceOn |
51 | Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors and . Proc Natl Acad Sci USA 1997;94:4318-4323 DOI |
52 | Fitzpatrik FA, Wynlda MA. Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J Biol Chem 1983;258(11):713-718 |
53 | Jiang C, Ting AT, Seed B. PPAR agonists inhibit production of monocyte inflammatory cytokines. Nature 1998;391(1);82-86 DOI PUBMED ScienceOn |
54 | Greene ME, Blumberg B, McBride OW, Yi HF, Kronquist K, Kwan K. Isolation of the human peroxisome proliferator activated receptor gamma cDNA : expression in hematopoietic cells and chromosomal mapping. Gene Expr 1995;4:281-299 PUBMED |
55 | Emrich LJ, Schlossman M, Genco RJ. Periodontal disease in noninsulin-dependent diabetes mellitus. J. Periodontal. 1991;62:123-130 DOI |
56 | Inoue H, Tanabe T, Umesono K. Feedback control of cyclooxygenase-2 expression through PPAR . J Biol Chem 2000;275(36):28028-28032 |
57 | Sarrazin P, Bkaily G, Hache R, Patry C, Dumais R, Rocha FA, de Brum-Fernandes AJ. Characterization of the prostaglandins receptors in human osteoblasts in culture. Prosstaglandins Leukot Essent Fatty Acids 2001;64:203-10 DOI ScienceOn |
58 | Kondo M, Oya-Ito T, Kumagai T, Osawa T, Uchida K. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. J Biol Chem 2001;276(15):12076-12083 DOI ScienceOn |
59 | Clark RB, Bailey DB, Hernandez TE, Hla T, Puddington L, Padula SJ. The Nuclear receptor PPAR and Immunoregulation : PPAR mediates inhibition of helper T cell responses. J Immunology 2000;164:1364-1371 |
60 | Maor G and Kamieli E. The insulin-sensitive glucose transporter (GLUT4) is involved in early bone growth in control and diabetic mice, but is regulated through the insulin-like growth factor I receptor. Endocrinology 1999;140:1841-1851 DOI ScienceOn |
61 | Offenbacher S, Heasman PA, Colllins JG. Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-444 PUBMED |
62 | Drew PD, Chavis JA. The cyclopentone prostaglandin 15-deoxy- 12,14-prostaglandin J2 represses NO, TNF- , and IL-12 production by micorglial cells. J Neuroimmunol 2001;115:28-35 DOI PUBMED ScienceOn |
63 | Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R. The human PPARgamma gene : organization, promoter analysis and expression. J Biol Chem 1997; 272:18779-18789 DOI ScienceOn |
64 | Suda M, Tanaka K, Natsui K, Usui T, Tanaka I, Fukushima M, Shigeno C, Konishi J, Narumiya S, Ichikawa A, Narumiya K. Prostglandin E receptor subtypes in mouse osteoblastic cell line. Endocrinology 1996;137:1698-1705 DOI ScienceOn |
65 | Klein DC and Raisz LG. Prostaglandins : Stimulation of bone resorption in tissue culture. Endocrinology 1970;86:1436-1440 DOI ScienceOn |
66 | Williams RC. Offenbacher S, Jeffcoat MK, Howell TH, Johnson HG, Hall CM, Wechter WJ, Goldhaber P. Indomethacin of flurbiprofen treatment of periodontitis in beagles : Effect on crevicular fluid arachidonic acid metabolites compared with effect on alveolar bone loss. J. Periodont Res 1988;23:134-140 DOI PUBMED |
67 | Shimizu N, Ozawa Y, Yamaguchi M, Goseki T, ohzeki K, Abiko Y. Induction of cox-2 expression by mechanical tension force in human periodontal ligament cells. J Periodontol 1998;69:670-677 DOI PUBMED ScienceOn |